EP3877395

RICHTER GEDEON NYRT.
Application Number
EP20768398A
Filing Date
Sep 2, 2020
Status
Granted And Under Opposition
Nov 4, 2022
Grant Date
Dec 7, 2022
External Links
Slate, Register

Biblio Summary

The patent EP3877395B1 was granted on Dec 7, 2022 by Richter Gedeon Nyrt. The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

INDUSTRIALE CHIMICA S.R.L.Sep 7, 2023ADMISSIBLE

The table below shows the patents of Richter Gedeon Nyrt. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2925324Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of SchizophreniaDec 30, 20202
EP2828396Method For The Production Of PolypeptidesApr 24, 20191
EP3212667Pharmaceutical Anti-Tnf-Alpha Antibody FormulationSep 19, 20183